|Day's Range||2,890.43 - 2,911.17|
|52 Week Range||2,488.03 - 2,916.50|
Live from the floor of the New York Stocks Exchange, Yahoo Finance's Jared Blikre joins Jen Rogers to break down the latest Chinese stocks under pressure.
Analysts and market bulls alike have been riding the wave of the so-called longest bull market in history, with the stock market at all-time highs. Enter the bear market. Market fluctuations will have a big impact on your portfolio, so it's important to know how a bear market might affect it.
A steady stream of robust earnings and economic data has virtually zapped volatility from U.S. stocks, but a coming freeze on share buybacks could challenge the market. Companies typically don’t repurchase their own shares in the month before reporting quarterly results because of regulations, and with the third quarter coming to an end, 86% of the S&P 500 will be temporarily restricted by Oct. 5, according to Goldman Sachs analysts led by David Kostin. Company demand can also trigger stock-price gains.
Investing.com - The S&P 500 closed higher on Tuesday as softer-than-expected tariffs imposed by the U.S. and China put the brakes on the prospect of a full-blown trade war, prompting a wave of buying across stocks.
Tilray CEO Brendan Kennedy shares his take on the future of medical and recreational marijuana with CNBC's Jim Cramer. Kennedy tells the "Mad Money" host that drug and alcohol makers should turn their focus to companies like his. Pharmaceutical companies have to start thinking about partnering with cannabis companies as a "hedge" against the burgeoning marijuana industry, Tilray TLRY CEO Brendan Kennedy told CNBC on Tuesday.
Markets subdued as China and America ratchet up tariffs on goods. Yahoo Finance's Seana Smith, Dion Rabouin, Kathy Jones, Sr. VP and Chief Fixed Income Strategist and Liz Young of BNY Mellon Snr. Investment Strategist, discuss.